These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 11454681

  • 21. Small antisense RNA to cyclin D1 generated by pre-tRNA splicing inhibits growth of human hepatoma cells.
    Lai D, Weng S, Wang C, Qi L, Yu C, Fu L, Chen W.
    FEBS Lett; 2004 Oct 22; 576(3):481-6. PubMed ID: 15498584
    [Abstract] [Full Text] [Related]

  • 22. Beta-catenin and cyclin D1 expression in human hepatocellular carcinoma.
    Ueta T, Ikeguchi M, Hirooka Y, Kaibara N, Terada T.
    Oncol Rep; 2002 Oct 22; 9(6):1197-203. PubMed ID: 12375019
    [Abstract] [Full Text] [Related]

  • 23. NTP Toxicology and Carcinogenesis Studies of Coumarin (CAS No. 91-64-5) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1993 Sep 22; 422():1-340. PubMed ID: 12616289
    [Abstract] [Full Text] [Related]

  • 24. Combined cyclin D1 overexpression and zinc deficiency disrupts cell cycle and accelerates mouse forestomach carcinogenesis.
    Fong LY, Mancini R, Nakagawa H, Rustgi AK, Huebner K.
    Cancer Res; 2003 Jul 15; 63(14):4244-52. PubMed ID: 12874033
    [Abstract] [Full Text] [Related]

  • 25. Continuous cell injury promotes hepatic tumorigenesis in cdc42-deficient mouse liver.
    van Hengel J, D'Hooge P, Hooghe B, Wu X, Libbrecht L, De Vos R, Quondamatteo F, Klempt M, Brakebusch C, van Roy F.
    Gastroenterology; 2008 Mar 15; 134(3):781-92. PubMed ID: 18325391
    [Abstract] [Full Text] [Related]

  • 26. Aberrant iNOS signaling is under genetic control in rodent liver cancer and potentially prognostic for the human disease.
    Calvisi DF, Pinna F, Ladu S, Pellegrino R, Muroni MR, Simile MM, Frau M, Tomasi ML, De Miglio MR, Seddaiu MA, Daino L, Sanna V, Feo F, Pascale RM.
    Carcinogenesis; 2008 Aug 15; 29(8):1639-47. PubMed ID: 18579559
    [Abstract] [Full Text] [Related]

  • 27. Neoplastic hepatocyte growth associated with cyclin D1 redistribution from the cytoplasm to the nucleus in mouse hepatocarcinogenesis.
    Yamamoto M, Tamakawa S, Yoshie M, Yaginuma Y, Ogawa K.
    Mol Carcinog; 2006 Dec 15; 45(12):901-13. PubMed ID: 17013836
    [Abstract] [Full Text] [Related]

  • 28. Overexpression of cyclin D1 is associated with elevated levels of MAP kinases, Akt and Pak1 during diethylnitrosamine-induced progressive liver carcinogenesis.
    Parekh P, Rao KV.
    Cell Biol Int; 2007 Jan 15; 31(1):35-43. PubMed ID: 17055752
    [Abstract] [Full Text] [Related]

  • 29. DDX3, a DEAD box RNA helicase, is deregulated in hepatitis virus-associated hepatocellular carcinoma and is involved in cell growth control.
    Chang PC, Chi CW, Chau GY, Li FY, Tsai YH, Wu JC, Wu Lee YH.
    Oncogene; 2006 Mar 30; 25(14):1991-2003. PubMed ID: 16301996
    [Abstract] [Full Text] [Related]

  • 30. Selective down-regulation of glioma-associated oncogene 2 inhibits the proliferation of hepatocellular carcinoma cells.
    Kim Y, Yoon JW, Xiao X, Dean NM, Monia BP, Marcusson EG.
    Cancer Res; 2007 Apr 15; 67(8):3583-93. PubMed ID: 17440069
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of cyclin D1 and cyclin E in 1,2-dimethylhydrazine dihydrochloride-induced rat colon carcinogenesis.
    Hur K, Kim JR, Yoon BI, Lee JK, Choi JH, Oh GT, Kim DY.
    J Vet Sci; 2000 Dec 15; 1(2):121-6. PubMed ID: 14614307
    [Abstract] [Full Text] [Related]

  • 32. Use of RNA interference to target cyclin E-overexpressing hepatocellular carcinoma.
    Li K, Lin SY, Brunicardi FC, Seu P.
    Cancer Res; 2003 Jul 01; 63(13):3593-7. PubMed ID: 12839946
    [Abstract] [Full Text] [Related]

  • 33. Comparison study of the expressions of myristoylated alanine-rich C kinase substrate in hepatocellular carcinoma, liver cirrhosis, chronic hepatitis, and normal liver.
    Masaki T, Tokuda M, Yoshida S, Nakai S, Morishita A, Uchida N, Funaki T, Kita Y, Funakoshi F, Nonomura T, Himoto T, Deguchi A, Kimura Y, Izuishi K, Wakabayashi H, Usuki H, Yoshiji H, Watanabe S, Kurokohchi K, Kuriyama S.
    Int J Oncol; 2005 Mar 01; 26(3):661-71. PubMed ID: 15703821
    [Abstract] [Full Text] [Related]

  • 34. [Establishment and cytogenetic characterization of a human hepatocellular carcinoma cell strain from the embolus in portal vein].
    Zhang M, Wen JM, Xu JM, Wang WS, Hu L, Xie D, Guan XY.
    Ai Zheng; 2002 Nov 01; 21(11):1203-7. PubMed ID: 12526216
    [Abstract] [Full Text] [Related]

  • 35. NTP Toxicology and Carcinogenesis Studies of 1-Amino-2,4-Dibromoanthraquinone (CAS No. 81-49-2) in F344/N Rats and B6C3F1 Mice (Feed Studies).
    National Toxicology Program .
    Natl Toxicol Program Tech Rep Ser; 1996 Aug 01; 383():1-370. PubMed ID: 12692653
    [Abstract] [Full Text] [Related]

  • 36. Abnormal expression of JUNB gene in hepatocellular carcinoma.
    Chang YS, Yeh KT, Yang MY, Liu TC, Lin SF, Chan WL, Chang JG.
    Oncol Rep; 2005 Mar 01; 13(3):433-8. PubMed ID: 15706412
    [Abstract] [Full Text] [Related]

  • 37. KLF6 transcription factor protects hepatocellular carcinoma-derived cells from apoptosis.
    Sirach E, Bureau C, Péron JM, Pradayrol L, Vinel JP, Buscail L, Cordelier P.
    Cell Death Differ; 2007 Jun 01; 14(6):1202-10. PubMed ID: 17347668
    [Abstract] [Full Text] [Related]

  • 38. Telomerase deletion limits progression of p53-mutant hepatocellular carcinoma with short telomeres in chronic liver disease.
    Lechel A, Holstege H, Begus Y, Schienke A, Kamino K, Lehmann U, Kubicka S, Schirmacher P, Jonkers J, Rudolph KL.
    Gastroenterology; 2007 Apr 01; 132(4):1465-75. PubMed ID: 17433324
    [Abstract] [Full Text] [Related]

  • 39. E2F8 contributes to human hepatocellular carcinoma via regulating cell proliferation.
    Deng Q, Wang Q, Zong WY, Zheng DL, Wen YX, Wang KS, Teng XM, Zhang X, Huang J, Han ZG.
    Cancer Res; 2010 Jan 15; 70(2):782-91. PubMed ID: 20068156
    [Abstract] [Full Text] [Related]

  • 40. [Expression of cyclins in hepatocellular carcinoma and its correlation to tumor cell apoptosis].
    Peng SH, Yang JF, Xie PP, Deng H, Li H, Feng DY.
    Ai Zheng; 2005 Jun 15; 24(6):695-8. PubMed ID: 15946481
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.